EXEL
Exelixis, Inc. · Healthcare
EVP and General Counsel Jeffrey Hessekiel sold $710K of Exelixis, Inc.
Sold$709,750
$28.39Price
25,000Shares
−4%Stake
What EXEL did after the filing
- The stock from Wed, Oct 30 close, $32.44
- +8.4%
- S&P 500, same days
- +4.2%
Measured over 30 trading days, to the Dec 12 close.
Traded Mon, Oct 28. Filed Wed, Oct 30, 2:04 PM ET, during the session. Returns use the Oct 30 close and the Dec 12 close. Not investment advice.